Exercise improves VO2max and body composition in androgen deprivation therapy-treated prostate cancer patients

Medicine and Science in Sports and Exercise

Volumn 49, Issue 8, 2017, Pages 1503-1510

  Wall, Bradley A ^a,b   Galvão, Daniel A ^a   Fatehee, Naeem ^a   Taaffe, Dennis R ^a,c   Spry, Nigel ^a,d,e   Joseph, David ^a,d,e   Hebert, Jeffrey J ^b   Newton, Robert U ^a,c  

^a EDITH COWAN UNIVERSITY   (Australia)

^b MURDOCH UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Aerobic; Cardiovascular disease; Randomized controlled trial; Resistance

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; AGED; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CARDIORESPIRATORY FITNESS; CONTROLLED STUDY; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; HUMAN; KINESIOTHERAPY; MALE; METABOLISM; MIDDLE AGED; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CARDIORESPIRATORY FITNESS; ENERGY METABOLISM; EXERCISE THERAPY; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PROSTATIC NEOPLASMS; RESISTANCE TRAINING;

EID: 85015686736     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0000000000001277     Document Type: Article

References (40)

1. Basaria S. Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth. J Androl. 2008; 29(5):534-9.
2. Basaria S, Muller DC, Carducci MA, Egan J, Dobs AS. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer. 2006;106(3):581-8.
3. Baumann FT, Zopf EM, Bloch W. Clinical exercise interventions in prostate cancer patients-A systematic review of randomized controlled trials. Support Care Cancer. 2012;20(2):221-33.
4. Blair SN, Kohl HW 3rd, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA. 1995;273(14):1093-8.
5. Compher C, Frankenfield D, Keim N, Roth-Yousey L. Best practice methods to apply to measurement of resting metabolic rate in adults: a systematic review. J Am Diet Assoc. 2006;106(6):881-903.
6. Culos-Reed SN, Robinson JW, Lau H, et al. Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Support Care Cancer. 2009; 18(5):591-9.
7. Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research ClinicsMortality Follow-up Study. N Engl JMed. 1988;319(21):1379-84.
8. Erikssen J. Physical fitness and coronary heart disease morbidity and mortality. A prospective study in apparently healthy, middle aged men. Acta Med Scand Suppl. 1986;711:189-92.
9. Galvao DA, Nosaka K, Taaffe DR, et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc. 2006;38(12):2045-52.
10. Galvao DA, Spry NA, Taaffe DR, et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int. 2008;102(1):44-7.
11. Galvao DA, Taaffe DR. Resistance exercise dosage in older adults: single-versus multiset effects on physical performance and body composition. J Am Geriatr Soc. 2005;53(12):2090-7.
12. Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010;28(2):340-7.
13. Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Acute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise response. J Urol. 2011;186(4):1291-7.
14. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10(3):141-6.
15. Greenspan SL, Coates P, Sereika SM, Nelson JB, Trump DL, Resnick NM. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab. 2005;90(12):6410-7.
16. Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1435-45.
17. Newton RU, Taaffe DR, Spry N, et al. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer. 2009;9:210.
18. Newton RU, Hakkinen K, Hakkinen A, McCormick M, Volek J, Kraemer WJ. Mixed-methods resistance training increases power and strength of young and older men. Med Sci Sports Exerc. 2002; 34(8):1367-75.
19. Nottin S, Walther G, Vinet A, et al. Reproducibility of automated pulse wave velocity measurement during exercise. Running head: pulse wave velocity during exercise. Arch Mal Coeur Vaiss. 2006;99(6): 564-8.
20. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: theOmronHEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit. 1996;1(1):55-61.
21. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38(4):932-7.
22. Reis C, Liberman S, Pompeo AC, Srougi M, Halpern A, Jacob Filho W. Body composition alterarions, energy expenditure and fat oxidation in elderly males suffering from prostate cancer, pre and post orchiectomy. Clinics (Sao Paulo). 2009;64(8):781-4.
23. Ruiz JR, Sui X, Lobelo F, et al. Association between muscular strength and mortality in men: prospective cohort study. BMJ. 2008;337:a439.
24. Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409-26.
25. Scott JM, Hornsby WE, Lane A, Kenjale AA, Eves ND, Jones LW. Reliability of maximal cardiopulmonary exercise testing in men with prostate cancer. Med Sci Sports Exerc. 2015;47(1):27-32.
26. Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003;21(9):1653-9.
27. Segal RJ, Reid RD, Courneya KS, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol. 2009;27(3):344-51.
28. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the ''androgen deprivation syndrome'' in men receiving androgen deprivation for prostate cancer. Arch Intern Med. 2006;166(4):465-71.
29. Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer. JAMA. 2005;294(2):238-44.
30. Smith MR. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology. 2004; 63(4):742-5.
31. Smith MR, Finkelstein JS, McGovern FJ, et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab. 2002;87(2):599-603.
32. Smith MR, Lee H, Nathan DM. Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab. 2006;91(4):1305-8.
33. Soares MJ, Shetty PS. Intra-individual variations in resting metabolic rates of human subjects. Hum Nutr Clin Nutr. 1986;40(5): 365-9.
34. Taaffe DR, Duret C, Wheeler S, Marcus R. Once-weekly resistance exercise improves muscle strength and neuromuscular performance in older adults. J Am Geriatr Soc. 1999;47(10): 1208-14.
35. Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177(6):2106-31.
36. Thompson WR, Gordon NF, Pescatello LS. ACSM's Guidelines for Exercise Testing and Prescription. Philadelphia, PA: Lippincott Williams & Wilkins; 2010. pp. 72-85.
37. Van Poppel H, Tombal B. Cardiovascular risk during hormonal treatment in patients with prostate cancer. Cancer Manag Res. 2011;3:49-55.
38. Vellas B, Guigoz Y, Garry PJ, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;15(2):116-22.
39. Wall BA, Galvao DA, Fatehee N, et al. Maximal exercise testing of men with prostate cancer being treated with androgen deprivation therapy. Med Sci Sports Exerc. 2014;46(12):2210-5.
40. Winters-Stone KM, Dieckmann N, Maddalozzo GF, Bennett JA, Ryan CW, Beer TM. Resistance exercise reduces body fat and insulin during androgen-deprivation therapy for prostate cancer. Oncol Nurs Forum. 2015;42(4):348-56.